Asset Details
Do you wish to reserve the book?
CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies
Do you wish to request the book?
CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies
2025
Overview
Long non-coding RNAs (lncRNAs) are a class of non-protein-coding RNAs that have over 200 nucleotides. Various studies have shown that aberrant expression of lncRNAs can lead to the development of different tumors. Furthermore, recent findings revealed that abnormal lncRNA expression can significantly influence cancer-related processes such as proliferation, migration, invasion, metastasis, and epithelial–mesenchymal transition. Colon cancer-associated transcript 2 (CCAT2), a type of lncRNA, was initially identified as an oncogene in colon cancer and subsequently identified as a prognostic biomarker in different cancers, including hepatocellular carcinoma, esophageal squamous cell carcinoma, ovarian cancer, lung cancer, breast cancer, and other tumors. Cumulative studies have revealed that the overexpression of CCAT2 is significantly correlated with tumor size, tumor node metastasis (TNM stage), tumor progression, and poor clinical outcomes. The significant role of CCAT2 in various gastrointestinal (GI) malignancies has drawn increased attention in recent years. In the present study, we reviewed recent literature concerning lncRNA CCAT2’s role in the development and progression of different GI cancers, including colorectal, gastric, hepatocellular, and oropharyngeal cancer, its interaction with cancer-related molecular mechanisms, and evaluate its potential as a diagnostic and prognostic biomarker in GI patients. In addition, this study shows that CCAT2 can be applied as a novel target for treatment strategies in gastrointestinal cancers.
Publisher
Springer International Publishing,Springer Nature B.V
Subject
/ Behavior
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Enzymes
/ Epithelial-Mesenchymal Transition - genetics
/ Gastrointestinal Neoplasms - drug therapy
/ Gastrointestinal Neoplasms - genetics
/ Gastrointestinal Neoplasms - pathology
/ Gene Expression Regulation, Neoplastic
/ Glioma
/ Humans
/ Kinases
/ Medicine
/ Oncology
/ Ovaries
/ Prostate
/ Proteins
/ Review
/ RNA, Long Noncoding - genetics
/ RNA, Long Noncoding - metabolism
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.